ATE445396T1 - 3-arylthioindol-2-carbonsäureamidderivate und ihre analoge als hemmer von caseinkinase i - Google Patents

3-arylthioindol-2-carbonsäureamidderivate und ihre analoge als hemmer von caseinkinase i

Info

Publication number
ATE445396T1
ATE445396T1 AT05785433T AT05785433T ATE445396T1 AT E445396 T1 ATE445396 T1 AT E445396T1 AT 05785433 T AT05785433 T AT 05785433T AT 05785433 T AT05785433 T AT 05785433T AT E445396 T1 ATE445396 T1 AT E445396T1
Authority
AT
Austria
Prior art keywords
caseinkinase
arylthioindole
analogues
inhibitors
acid amide
Prior art date
Application number
AT05785433T
Other languages
English (en)
Inventor
William Arthur Metz
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE445396T1 publication Critical patent/ATE445396T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AT05785433T 2004-08-19 2005-08-19 3-arylthioindol-2-carbonsäureamidderivate und ihre analoge als hemmer von caseinkinase i ATE445396T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60334804P 2004-08-19 2004-08-19
PCT/US2005/029306 WO2006023590A1 (en) 2004-08-19 2005-08-19 3-ARYLTHIOINDOLE-2-CARBOXAMIDE DERIVATIVES AND ANALOGS THEREOF AS INHIBITORS OF CASEIN KINASE Iϵ

Publications (1)

Publication Number Publication Date
ATE445396T1 true ATE445396T1 (de) 2009-10-15

Family

ID=35311784

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05785433T ATE445396T1 (de) 2004-08-19 2005-08-19 3-arylthioindol-2-carbonsäureamidderivate und ihre analoge als hemmer von caseinkinase i

Country Status (19)

Country Link
US (1) US8008340B2 (de)
EP (1) EP1791537B1 (de)
JP (1) JP4931814B2 (de)
KR (1) KR20070045264A (de)
CN (1) CN101039666A (de)
AT (1) ATE445396T1 (de)
AU (1) AU2005277460A1 (de)
BR (1) BRPI0514397A (de)
CA (1) CA2577511A1 (de)
DE (1) DE602005017162D1 (de)
DK (1) DK1791537T3 (de)
ES (1) ES2334927T3 (de)
IL (1) IL181155A0 (de)
MX (1) MX2007001077A (de)
PL (1) PL1791537T3 (de)
PT (1) PT1791537E (de)
RU (1) RU2391098C2 (de)
SI (1) SI1791537T1 (de)
WO (1) WO2006023590A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110172244A1 (en) * 2008-02-22 2011-07-14 Irm Llc Compounds and compositions as modulators of gpr119 activity
JP4748823B2 (ja) * 2009-02-12 2011-08-17 株式会社ファルマデザイン カゼインキナーゼ１δ及びカゼインキナーゼ１ε阻害剤
MX2012004997A (es) * 2009-10-28 2012-06-12 Pfizer Derivados de imidazol como inhibidores de la caseina quinasa.
WO2011140164A1 (en) * 2010-05-06 2011-11-10 Merck Sharp & Dohme Corp. Aza-indole derivatives useful as modulators of faah
CN104803997A (zh) * 2010-08-09 2015-07-29 株式会社创药分子设计 酪蛋白激酶1δ及酪蛋白激酶1ε抑制剂
KR101350077B1 (ko) * 2010-12-13 2014-01-14 한국화학연구원 신규한 3-인돌리논 유도체 및 이를 포함하는 조성물
EP2651405A2 (de) * 2010-12-14 2013-10-23 Electrophoretics Limited Casein-kinase-1 (ck1)-inhibitoren
NZ728724A (en) 2012-05-11 2018-03-23 Reset Therapeutics Inc Carbazole-containing sulfonamides as cryptochrome modulators
TWI690521B (zh) 2014-04-07 2020-04-11 美商同步製藥公司 作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類
WO2018133835A1 (en) * 2017-01-20 2018-07-26 National Institute Of Biological Sciences, Beijing Nucleoside analogue regulating mammalian circadian rhythm
CN115349015A (zh) * 2020-02-21 2022-11-15 北京大学 用于调节睡眠的药剂和方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3705934A1 (de) * 1987-02-25 1988-09-08 Nattermann A & Cie Indolyl-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
BR9405737A (pt) * 1993-02-24 1995-12-05 Merck & Co Inc Composto processo de inibição de transcriptase reserva de HIV, processo de prevenção contra a infecção pelo HIV ou de tratamento da infecção pelo HIV, composição farmacêutica útil para a inibição da transcriptase reserva de HIV, e, útil para a prevenção ou tratamento de infecção pelo HIV ou para o tratamento da AIDS ou ARC
US5807693A (en) * 1994-11-23 1998-09-15 Icos Corporation Calcineurin inhibitory compounds and anchoring protein
KR100722176B1 (ko) * 1999-06-08 2007-05-29 아벤티스 파마슈티칼스 인크. 일주기 리듬 단백질을 변화시키기 위한 스크리닝 방법
AU2003220190A1 (en) * 2002-03-13 2003-09-29 Pharmacia & Upjohn Company Llc Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
WO2004005501A1 (en) * 2002-07-08 2004-01-15 Bayer Healthcare Ag Regulation of human casein kinase i epsilon
JP4335136B2 (ja) * 2002-08-09 2009-09-30 メルク エンド カムパニー インコーポレーテッド チロシンキナーゼ阻害薬
CN100439367C (zh) * 2003-12-11 2008-12-03 安万特药物公司 作为酪蛋白激酶Iε抑制剂的取代的1H-吡咯并[3,2-b、3,2-c和2,3-c]吡啶-2-甲酰胺以及相关类似物

Also Published As

Publication number Publication date
EP1791537A1 (de) 2007-06-06
PT1791537E (pt) 2010-01-19
EP1791537B1 (de) 2009-10-14
PL1791537T3 (pl) 2010-04-30
DE602005017162D1 (de) 2009-11-26
RU2391098C2 (ru) 2010-06-10
US20070142454A1 (en) 2007-06-21
JP4931814B2 (ja) 2012-05-16
RU2007109813A (ru) 2008-09-27
SI1791537T1 (sl) 2010-02-26
MX2007001077A (es) 2007-04-17
US8008340B2 (en) 2011-08-30
ES2334927T3 (es) 2010-03-17
CN101039666A (zh) 2007-09-19
DK1791537T3 (da) 2010-03-01
WO2006023590A1 (en) 2006-03-02
JP2008510704A (ja) 2008-04-10
IL181155A0 (en) 2007-07-04
AU2005277460A1 (en) 2006-03-02
KR20070045264A (ko) 2007-05-02
BRPI0514397A (pt) 2008-06-10
CA2577511A1 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
IL181155A0 (en) 3-arylthioindole-2-carboxamide derivatives and analogs thereof as inhibitors of casein kinase i?á
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
EA200900152A1 (ru) Ингибиторы пирролотриазинкиназы
WO2007056517A3 (en) Pharmaceutical salts and polymorphs of n- (5-chl0r0-2-pyridinyl) -2- [ [4- [ (dimethylamino) iminomethyl] benzoyl] amino] -5-meth oxy-benzamide, a factor xa inhibitor
EA201070167A1 (ru) Замещенные производные индазола, активные как ингибиторы киназы
EA201101671A1 (ru) Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина
TW200613306A (en) Imidazotriazines as protein kinase inhibitors
TNSN06411A1 (en) Pyrimidine urea derivatives as kinase inhibitors
EA200970611A1 (ru) Замещенные пиразолохиназолиновые производные, способ их получения и их применение в качестве ингибиторов киназы
IL198979A (en) Enzyme inhibitors diacylglycerol o-acetyltransferase type 1
NO20091590L (no) Heterocykliske amidforbindelser anvendbare som kinaseinhibitorer
WO2008060907A3 (en) Pyrrolo-pyridine kinase inhibitors
NZ593295A (en) Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinase inhibitor
DK1539700T3 (da) 8-hydroxyquinolin-derivater
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
WO2004001059A3 (en) Heterocyclic inhibitors of kinases
AU2009258496A8 (en) Sulfur-containing heterocyclic derivative having beta-secretase-inhibiting activity
TW200728307A (en) Novel spirochromanone derivatives
MY144232A (en) 5-substituted-2-phenylamino benzamides as mek inhibitors
SE0400284D0 (sv) Novel compounds
WO2006007378A3 (en) Pyrrolotriazine kinase inhibitors
MX2009011059A (es) Aminopirimidinas utiles como inhibidores de cinasas.
ATE404536T1 (de) Substituierte chinolinderivate als inhibitoren von mitotischem kinesin
MX2007004248A (es) Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa.
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1791537

Country of ref document: EP

REN Ceased due to non-payment of the annual fee